Calista Therapeutics Email Formats

Biotechnology Research • Lincoln, Rhode Island, United States • 1-10 Employees

Key Contact at Calista Therapeutics

Sarah Thomas

Senior Director Of Operations

Company overview

Headquarters	32 RIVERSIDE DRIVE, LINCOLN, Rhode Island 02865, US
Websites	calistatherapeutics.net calistatherapeutics.com
NAICS	541714
Founded	2012
Employees	1-10
Socials

About Calista Therapeutics

Calista Therapeutics was founded in 2012 by peptide therapeutic pioneer and biotech entrepreneur, Andrew Mallon, building upon years of research and business experience in discovering and developing peptide drugs. Calista scientists are today developing these promising leads to create more effective and safe medicines for the treatment of cystic fibrosis, dry eye, radiation damage, neuroprotection and other indications. Our expertise in the pharmacology and development of peptide drugs that interact with key cellular disease targets.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

Explore Calista Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2013-12-01	9	N/A

Funding Insights

Number of funding rounds

Frequently asked questions

Calista Therapeutics is located in Lincoln, Rhode Island, US.

Calista Therapeutics was founded in 2012, making it 14 years old. The company has established itself as a significant player in its industry over this time.

Calista Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Calista Therapeutics

Sarah Thomas

Senior Director Of Operations

4.8

40,000 users